The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial.

The potential determinants of the changes in chronic obstructive pulmonary disease (COPD) mortality were evaluated using both the Multiple Risk Factor Intervention Trial (MRFIT) screenees, the longitudinal analysis of the participants, and the differences in special intervention (SI) and usual care (UC) groups. COPD was the underlying cause for only one third of all death certificates listing COPD. Small changes in classification will have a major impact on reported COPD death rates. Cigarette smoking is clearly the primary determinant of COPD mortality. Decreased pulmonary function is an independent risk factor for coronary heart disease (CHD) mortality. Smoking cessation results in a slower rate of decline in pulmonary function over time, especially among heavy smokers. Careful evaluation of smoking cessation, including repeat chemical measures, suggest that the percentage of long-term quitters, especially among heavy smokers has been overestimated. The low percentage of quitters substantially reduced the power to detect an intervention effect. The increased cigarette smoking among recent older cohorts, and failure to substantially reduce smoking, especially among heavy smokers, may be an important factor accounting for the failure to note a decline in COPD mortality among older persons.

[1]  R. Gillum,et al.  Coronary heart disease in the elderly. , 1988, Comprehensive therapy.

[2]  C. Bouchard,et al.  Familial aggregation in physical fitness, coronary heart disease risk factors, and pulmonary function measurements. , 1987, Preventive medicine.

[3]  N. Anthonisen,et al.  Airways obstruction and the risk for lung cancer. , 1987, Annals of internal medicine.

[4]  J. McGinnis,et al.  Tobacco and health: trends in smoking and smokeless tobacco consumption in the United States. , 1987, Annual review of public health.

[5]  H. Wedel,et al.  Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. , 1986, American journal of epidemiology.

[6]  K P Offord,et al.  Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. , 1986, Annals of internal medicine.

[7]  A. G. Duchene,et al.  Quality control aspects of pulmonary function testing in the Multiple Risk Factor Intervention Trial. , 1986, Controlled clinical trials.

[8]  J. Ockene Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. , 1986, Preventive medicine.

[9]  T. Beaty,et al.  Familial aggregation in chronic obstructive pulmonary disease: Use of the loglinear model to analyze intermediate environmental and genetic risk factors , 1985, Genetic epidemiology.

[10]  T. Beaty,et al.  Effects of pulmonary function on mortality. , 1985, Journal of chronic diseases.

[11]  F. Speizer,et al.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.

[12]  W. Kannel,et al.  Vital capacity as a predictor of cardiovascular disease: the Framingham study. , 1983, American heart journal.

[13]  A. Siegelaub,et al.  Lung function and risk of myocardial infarction and sudden cardiac death. , 1976, The New England journal of medicine.

[14]  W. Kannel,et al.  Pulmonary Function: Relation to Aging, Cigarette Habit, and Mortality , 1975 .

[15]  H. Blackburn,et al.  Lung function as a risk factor for coronary heart disease. , 1972, American journal of public health.

[16]  M. Higgins,et al.  Predictors of mortality in the adult population of Tecumseh. , 1970, Archives of environmental health.

[17]  P. W. Bowman,et al.  PHS Public Health Service , 1963 .